← FDA Drug Approvals (Drugs@FDA)

SILDENAFIL CITRATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: RUBICON RESEARCH · Approved 2018-06-11

Drug application

FDA Application #

ANDA204882

Application type

Abbreviated New Drug Application (Generic)

Brand name

SILDENAFIL CITRATE

Generic name

SILDENAFIL

Active ingredients

SILDENAFIL CITRATE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

RUBICON RESEARCH

Manufacturer

Advagen Pharma Ltd

First approval

2018-06-11

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown